Hai Feng
- Co-authors
- Alfred S.L. ChengJoseph J.�Y. SungZhuo YuKa‐Fai ToJun YuMay S. LiYueqiu GaoMiranda G.S. Yap
- Topics
- MicroRNA in disease regulation (3 papers)Cancer Mechanisms and Therapy (3 papers)Drug Transport and Resistance Mechanisms (3 papers)
- Journals
- Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Hai Feng
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 667
- Cancer Research 259
- Oncology 169
- Epidemiology 132
- Immunology 121
Countries citing papers authored by Hai Feng
This map shows the geographic impact of Hai Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Feng more than expected).
Fields of papers citing papers by Hai Feng
This network shows the impact of papers produced by Hai Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Feng. The network helps show where Hai Feng may publish in the future.
Co-authorship network of co-authors of Hai Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Hai Feng. A scholar is included among the top collaborators of Hai Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Feng. Hai Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 13 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma | 15 |
| 9 | 6 | |
| 10 | 20 | |
| 11 | 1 | |
| 12 | 22 | |
| 13 | 19 | |
| 14 | 40 | |
| 15 | 27 | |
| 16 | 55 | |
| 17 | 19 | |
| 18 | 180 | |
| 19 | 102 | |
| 20 | 114 |
About Hai Feng
Hai Feng is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer Mechanisms and Therapy (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Cancer Research (259 citations), Hepatology (98 citations) and Molecular Biology (667 citations). Hai Feng has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Alfred S.L. Cheng, Joseph J.�Y. Sung, Zhuo Yu, Ka‐Fai To, Jun Yu, May S. Li, Yueqiu Gao, Miranda G.S. Yap, Niki S.C. Wong and Peter Morin Nissom. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.